Differentiated thyroid cancer shows a comparable prognosis in patients with immunocompromised vs immunocompetent status, a ...

Transcript: Lori Wirth, MD: Hello, and welcome to Cure Expert Connections on differentiated thyroid cancer. I’m Lori Wirth. I’m an associate professor of medicine at Harvard Medical School in Boston, ...

The MarketWatch News Department was not involved in the creation of this content. -- Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with ...

Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid ...

More than one-third of patients treated for differentiated thyroid cancer reported elevated anxiety and more than 15% reported a high level of depression at an annual follow-up, according to study ...

Please provide your email address to receive an email when new articles are posted on . Most patients with differentiated thyroid cancer on levothyroxine suppression therapy do not have a ...

This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...

A double-blind, randomized, placebo-controlled trial of l-glutamine for the severe oral mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer. This is an ASCO ...

An open-label, single-arm, dose escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of the ATR inhibitor SC0245 in advanced solid ...